
Senseonics Investor Relations Material
Latest events

Q1 2025
Senseonics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Senseonics Holdings Inc
Access all reports
Senseonics Holdings Inc. is a medical technology company specializing in continuous glucose monitoring (CGM) systems for people with diabetes. The company’s flagship product, the Eversense CGM System, includes a long-term implantable sensor, a wearable transmitter, and a mobile app, providing real-time glucose readings and trend data. Eversense is designed to reduce the frequency of sensor replacements compared to traditional CGM systems. The company is headquartered in Germantown, Maryland, and its shares are listed on the NYSE.
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
SENS
Country
🇺🇸 United States